The BalancedInvestor Club

Diagnostics Research Industry Analysis

58 companies analyzed • Returns from -625.4% to +410.7%

Company List (59 Results)

View:
Sort:

Industry Performance

(58/58 companies)
2025-09-02 → 2026-08-31
Weighted Avg
+20.7%
Best
+410.7%
Worst
-625.4%
Returns Distribution
Top 5
1. BDSX+410.7%2. ADVB+302.8%3. BIAF+295.8%4. TWST+166.7%5. CDNA+128.6%
Bottom 5
1. WGSWW-625.4%2. NOTV-497.1%3. NOTVQ-497.1%4. PRPH-270.4%5. MDXH-160.9%

BDSX

+410.7%

Biodesix Inc

ADVB

+302.8%

Advanced Biomed Inc. Common Stock

BIAF

+295.8%

bioAffinity Technologies, Inc.

TWST

+166.7%

Twist Bioscience Corp

CDNA

+128.6%

CareDx Inc

MBAI

+126.3%

CheckCap Ltd

PSNL

+125.0%

Personalis Inc

PRE

+117.0%

Prenetics Global Ltd

GRAL

+92.1%

GRAIL, LLC

GH

+87.2%

Guardant Health Inc

CHEK

+83.3%

Check Cap Ltd

EXAS

+78.2%

EXACT Sciences Corporation

ILMN

+78.1%

Illumina Inc

ISPC

+77.6%

iSpecimen Inc

NEOG

+71.8%

Neogen Corporation

NEO

+71.0%

NeoGenomics Inc

NTRA

+64.3%

Natera Inc

PRPO

+58.6%

Precipio Inc

CRL

+58.1%

Charles River Laboratories

IMDX

+41.1%

Insight Molecular Diagnostics Inc.

1–20 of 59
Page 1 of 3
Methodology

The Weighted Average return (+20.7%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

53 companies with market cap data included: BDSX, ADVB, BIAF, TWST, CDNA, MBAI, PSNL, PRE, GRAL, GH and 43 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer